Drug Search Results
More Filters [+]

JW-0302

Alternative Names: JW-0302, JW 0302, JW0302, C-2206, C 2206, C2206
Latest Update: 2024-03-20
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: Unknown

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: JW
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for JW-0302

Countries in Clinic: Korea

Active Clinical Trial Count: 1

Highest Development Phases

Phase 1: Healthy Volunteers

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

JW22106

P1

Completed

Healthy Volunteers

2023-06-09

28%

Recent News Events